Variant report
Variant | nsv1023430 |
---|---|
Chromosome Location | chr5:8271302-8291305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141423126 | chr5:8280800-8280801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560464263 | chr5:8280809-8280810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73045048 | chr5:8280815-8280816 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs6880841 | chr5:8280840-8280841 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs546285601 | chr5:8280880-8280881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143362798 | chr5:8280886-8280887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538994538 | chr5:8280915-8280916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527549428 | chr5:8280977-8280978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546702184 | chr5:8281024-8281025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559110587 | chr5:8281053-8281054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1506116 | chr5:8281056-8281057 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs535101574 | chr5:8281062-8281063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181151451 | chr5:8281065-8281066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs60331175 | chr5:8281081-8281082 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs529379375 | chr5:8281083-8281084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1506117 | chr5:8281086-8281087 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs1506118 | chr5:8281141-8281142 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs59742087 | chr5:8281154-8281155 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs76530875 | chr5:8281180-8281181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558899642 | chr5:8281202-8281203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528205152 | chr5:8281270-8281271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114609598 | chr5:8281272-8281273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561963196 | chr5:8281275-8281276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75747765 | chr5:8281292-8281293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550860600 | chr5:8281327-8281328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1506119 | chr5:8281329-8281330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs79721995 | chr5:8281348-8281349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186036368 | chr5:8281353-8281354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs386685245 | chr5:8281379-8281380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs70940801 | chr5:8281380-8281381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111773714 | chr5:8281393-8281394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552633634 | chr5:8281472-8281473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566064909 | chr5:8281475-8281476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs58737768 | chr5:8281482-8281483 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs376167301 | chr5:8281501-8281502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs61607420 | chr5:8281509-8281510 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs188931675 | chr5:8281514-8281515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555528323 | chr5:8288030-8288031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79574392 | chr5:8288126-8288127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142500585 | chr5:8288161-8288162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531260524 | chr5:8288189-8288190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114112107 | chr5:8288200-8288201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573897254 | chr5:8289001-8289002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561948253 | chr5:8289003-8289004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73045069 | chr5:8289065-8289066 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs1506125 | chr5:8289122-8289123 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs368819673 | chr5:8289123-8289124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183275066 | chr5:8289152-8289153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4607327 | chr5:8289159-8289160 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs187826454 | chr5:8289170-8289171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:8280800-8281600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:8288000-8288200 | Enhancers | Fetal Lung | lung |
3 | chr5:8289000-8290200 | Enhancers | Fetal Brain Male | brain |
4 | chr5:8289200-8289600 | Enhancers | Fetal Muscle Trunk | muscle |